ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,038Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 3647

$1.8M Total Retail Price of All Prescriptions

Rank: 45 out of 3647

1,080 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 1,080 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 1,080 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,280 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,036 916 1 1
LEVOTHYROXINE SODIUM 866 757 2 5
AMLODIPINE BESYLATE 687 626 3 2
LISINOPRIL 669 575 4 4
METOPROLOL TARTRATE 642 571 5 7
HYDROCODONE-ACETAMINOPHEN 642 490 S3 5 12
OMEPRAZOLE 523 437 7 3
WARFARIN SODIUM 513 403 8 15
MIRTAZAPINE 492 475 9 63
DONEPEZIL HCL 462 435 10 30
TRAMADOL HCL 458 407 11 22
FUROSEMIDE 429 388 12 8
ZOLPIDEM TARTRATE 405 324 13 14
NAMENDA 369 359 14 49
NEXIUM 327 258 15 44
METFORMIN HCL 318 255 16 6
SERTRALINE HCL 314 259 17 27
PRAVASTATIN SODIUM 311 278 18 16
POTASSIUM CHLORIDE 309 282 19 24
GABAPENTIN 301 208 20 17
ATORVASTATIN CALCIUM 296 257 21 13
CRESTOR 238 196 22 19
ATENOLOL 235 177 23 10
ALENDRONATE SODIUM 221 206 24 23
TAMSULOSIN HCL 199 161 25 28
CITALOPRAM HBR 199 170 25 25
CLOPIDOGREL 196 180 27 26
CARVEDILOL 190 166 28 20
ADVAIR DISKUS 190 140 28 52
HYDROCHLOROTHIAZIDE 184 159 30 9
HYDRALAZINE HCL 181 173 31 81
DIOVAN 174 150 32 40
METOPROLOL SUCCINATE 169 158 33 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 141 34 36
NIFEDIPINE ER 166 132 35 67
RISPERIDONE 162 139 36 83
LEVETIRACETAM 157 86 37 122
ESCITALOPRAM OXALATE 156 123 38 65
CIPROFLOXACIN HCL 155 140 39 53
FENTANYL 155 133 S2 39 147
FLUTICASONE PROPIONATE 143 121 41 32
IPRATROPIUM-ALBUTEROL 142 128 42 150
AZITHROMYCIN 140 123 43 34
PLAVIX 136 126 44 39
LANTUS 132 125 45 59
OXYCODONE HCL 131 46 S2 46 75
CYMBALTA 125 82 47 79
DIOVAN HCT 121 107 48 80
DIVALPROEX SODIUM 120 55 49 131
DIGOXIN 117 113 50 51
LYRICA 114 68 51 120
NOVOLIN R 111 106 52 139
MELOXICAM 111 102 52 33
SANTYL 110 108 54 233
SPIRIVA 109 93 55 93
ISOSORBIDE MONONITRATE ER 108 94 56 56
OXYCODONE-ACETAMINOPHEN 106 86 S2 57 91
FAMOTIDINE 105 102 58 61
RAMIPRIL 104 95 59 101
OLANZAPINE 98 70 60 240
CLONIDINE HCL 97 81 61 46
TRAZODONE HCL 96 73 62 64
EXELON 95 93 63 129
PREDNISONE 95 71 63 43
MEGESTROL ACETATE 93 87 R 65 138
OXYCONTIN 92 62 S2 66 234
METOCLOPRAMIDE HCL 91 81 67 135
LOVASTATIN 91 86 67 21
GLYBURIDE 90 73 R 69 54
IBUPROFEN 89 36 70 55
FENOFIBRATE 87 57 71 50
QUETIAPINE FUMARATE 86 67 72 89
TRICOR 86 65 72 144
LOSARTAN POTASSIUM 86 86 72 11
CYCLOBENZAPRINE HCL 86 43 R 72 98
DILTIAZEM 24HR CD 84 62 76 155
SINGULAIR 80 52 77 90
OXYBUTYNIN CHLORIDE ER 77 71 78 169
VENLAFAXINE HCL ER 77 62 78 181
FLUOXETINE HCL 77 29 78 68
MORPHINE SULFATE ER 77 28 S2 78 163
PHENYTOIN SODIUM EXTENDED 74 39 82 199
NITROFURANTOIN MONO-MACRO 73 72 83 268
POLYETHYLENE GLYCOL 3350 72 67 84 143
JANUVIA 71 48 85 72
LACTULOSE 71 26 85 128
CARBIDOPA-LEVODOPA 71 42 85 127
MONTELUKAST SODIUM 70 45 88 160
ZETIA 70 55 88 96
PANTOPRAZOLE SODIUM 70 46 88 38
DILTIAZEM HCL 67 56 91 253
PAROXETINE HCL 66 39 92 60
ALLOPURINOL 66 56 92 37
DOXAZOSIN MESYLATE 65 63 94 57
PROMETHAZINE HCL 65 52 R 94 182
LIDODERM 64 60 96 108
LIPITOR 64 58 96 113
KLOR-CON M20 63 59 98 121
LEVOFLOXACIN 63 52 98 87
NAPROXEN 62 29 100 70
AMITRIPTYLINE HCL 62 34 R 100 105
LOSARTAN-HYDROCHLOROTHIAZIDE 62 57 100 48
INSULIN SYRINGE 60 51 103 76
OXYCODONE HCL-ACETAMINOPHEN 59 33 S2 104 104
ROPINIROLE HCL 58 45 105 151
CELEBREX 58 56 105 111
EVISTA 58 46 105 184
FINASTERIDE 58 58 105 66
LEXAPRO 57 45 109 177
PROCRIT 57 57 109 398
DIVALPROEX SODIUM ER 57 32 109 289
CARISOPRODOL 56 25 R 112 115
LAMOTRIGINE 56 23 112 266
NIASPAN 56 33 112 175
VERAPAMIL ER 55 55 115 99
AGGRENOX 53 53 116 267
BUPROPION XL 53 41 116 229
OXYBUTYNIN CHLORIDE 53 42 116 107
FLUDROCORTISONE ACETATE 53 45 116 456
PROAIR HFA 52 31 120 62
PROPRANOLOL HCL 52 38 120 156
ANDROGEL 51 30 S3 122 318
ONDANSETRON HCL 51 42 122 383
METFORMIN HCL ER 50 49 124 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.